Advanced

Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls

Brooks-Worrell, B.; Tree, T.; Mannering, S. I.; Durinovic-Bello, I.; James, E.; Gottlieb, P.; Wong, S.; Zhou, Z.; Yang, L. and Cilio, Corrado LU , et al. (2011) In Diabetes/Metabolism Research Reviews 27(8). p.737-745
Abstract
Background Type 1 diabetes (T1D) is a cell-mediated autoimmune disease characterized by destruction of the pancreatic islet cells. The use of cryopreserved cells is preferable to the use of freshly isolated cells to monitor clinical trials to decrease assay and laboratory variability. Methods The T-Cell Workshop Committee of the Immunology of Diabetes Society compared two widely accepted T-cell freezing protocols (warm and cold) to freshly isolated peripheral blood mononuclear cells from patients with T1D and controls in terms of recovery, viability, cell subset composition, and performance in functional assays currently in use in T1D-related research. Nine laboratories participated in the study with four different functional assays... (More)
Background Type 1 diabetes (T1D) is a cell-mediated autoimmune disease characterized by destruction of the pancreatic islet cells. The use of cryopreserved cells is preferable to the use of freshly isolated cells to monitor clinical trials to decrease assay and laboratory variability. Methods The T-Cell Workshop Committee of the Immunology of Diabetes Society compared two widely accepted T-cell freezing protocols (warm and cold) to freshly isolated peripheral blood mononuclear cells from patients with T1D and controls in terms of recovery, viability, cell subset composition, and performance in functional assays currently in use in T1D-related research. Nine laboratories participated in the study with four different functional assays included. Results The cold freezing method yielded higher recovery and viability compared with the warm freezing method. Irrespective of freezing protocol, B cells and CD8+ T cells were enriched, monocyte fraction decreased, and islet antigen-reactive responses were lower in frozen versus fresh cells. However, these results need to take in to account that the overall response to islet autoantigens was low in some assays. Conclusions In the current study, none of the tested T-cell functional assays performed well using frozen samples. More research is required to identify a freezing method and a T-cell functional assay that will produce responses in patients with T1D comparable to responses using fresh peripheral blood mononuclear cells. Copyright (C) 2011 John Wiley & Sons, Ltd. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
T cells, proliferation, ELISPOT, tetramer, cryopreservation, CFSE, islet, antigens, type 1 diabetes
in
Diabetes/Metabolism Research Reviews
volume
27
issue
8
pages
737 - 745
publisher
John Wiley & Sons
external identifiers
  • wos:000300108000004
  • scopus:80755176918
ISSN
1520-7552
DOI
10.1002/dmrr.1245
language
English
LU publication?
yes
id
8aa2f865-c71d-4423-9438-7fdd4f4e41b4 (old id 2378564)
date added to LUP
2012-04-02 09:18:27
date last changed
2017-11-12 03:11:40
@article{8aa2f865-c71d-4423-9438-7fdd4f4e41b4,
  abstract     = {Background Type 1 diabetes (T1D) is a cell-mediated autoimmune disease characterized by destruction of the pancreatic islet cells. The use of cryopreserved cells is preferable to the use of freshly isolated cells to monitor clinical trials to decrease assay and laboratory variability. Methods The T-Cell Workshop Committee of the Immunology of Diabetes Society compared two widely accepted T-cell freezing protocols (warm and cold) to freshly isolated peripheral blood mononuclear cells from patients with T1D and controls in terms of recovery, viability, cell subset composition, and performance in functional assays currently in use in T1D-related research. Nine laboratories participated in the study with four different functional assays included. Results The cold freezing method yielded higher recovery and viability compared with the warm freezing method. Irrespective of freezing protocol, B cells and CD8+ T cells were enriched, monocyte fraction decreased, and islet antigen-reactive responses were lower in frozen versus fresh cells. However, these results need to take in to account that the overall response to islet autoantigens was low in some assays. Conclusions In the current study, none of the tested T-cell functional assays performed well using frozen samples. More research is required to identify a freezing method and a T-cell functional assay that will produce responses in patients with T1D comparable to responses using fresh peripheral blood mononuclear cells. Copyright (C) 2011 John Wiley & Sons, Ltd.},
  author       = {Brooks-Worrell, B. and Tree, T. and Mannering, S. I. and Durinovic-Bello, I. and James, E. and Gottlieb, P. and Wong, S. and Zhou, Z. and Yang, L. and Cilio, Corrado and Reichow, J. and Menart, B. and Rutter, R. and Schreiner, R. and Pham, M. and de Marquesini, L. Petrich and Lou, O. and Scotto, M. and Mallone, R. and Schloot, N. C.},
  issn         = {1520-7552},
  keyword      = {T cells,proliferation,ELISPOT,tetramer,cryopreservation,CFSE,islet,antigens,type 1 diabetes},
  language     = {eng},
  number       = {8},
  pages        = {737--745},
  publisher    = {John Wiley & Sons},
  series       = {Diabetes/Metabolism Research Reviews},
  title        = {Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls},
  url          = {http://dx.doi.org/10.1002/dmrr.1245},
  volume       = {27},
  year         = {2011},
}